Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Topical Versus Injection PRP for Olfactory Dysfunction

NCT: NCT07151703 · RECRUITING

NCT IDNCT07151703
StatusRECRUITING
Start Date2025-09-11
Completion2028-12-31
SponsorTaipei Veterans General Hospital, Taiwan (OTHER_GOV)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to determine whether two different delivery methods of autologous platelet-rich plasma (PRP) can improve olfactory function in adults with persistent olfactory dysfunction lasting more than three months. The main questions it aims to answer are: 1. Does carrier-assisted topical application of PRP lead to comparable or better improvement in smell function than intranasal injection of PRP? 2. Which method provides greater patient comfort and fewer adverse effects? Researchers will compare carrier-assisted topical PRP application to intranasal PRP injection to see if one approach is more effective in restoring olfactory function. Participants will: 1. Receive a single PRP treatment delivered either by injection or via a PRP-soaked carrier placed into the olfactory cleft. 2. Continue daily olfactory training for three months following the intervention. 3. Undergo smell testing (Sniffin' Sticks) before and after treatment and complete quality-of-life questionnaires.

Frequently Asked Questions

What is Topical Versus Injection PRP for Olfactory Dysfunction?

Topical Versus Injection PRP for Olfactory Dysfunction is a clinical trial registered under NCT07151703. Current status: RECRUITING.

What is the status of NCT07151703?

The current status of NCT07151703 (Topical Versus Injection PRP for Olfactory Dysfunction) is: RECRUITING.

When did Topical Versus Injection PRP for Olfactory Dysfunction start?

Topical Versus Injection PRP for Olfactory Dysfunction started on 2025-09-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑